621 related articles for article (PubMed ID: 34065983)
1. Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities.
Blijlevens M; Li J; van Beusechem VW
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065983
[TBL] [Abstract][Full Text] [Related]
2. Structural studies of the endogenous spliceosome - The supraspliceosome.
Sperling J; Sperling R
Methods; 2017 Aug; 125():70-83. PubMed ID: 28412289
[TBL] [Abstract][Full Text] [Related]
3. Emerging roles of spliceosome in cancer and immunity.
Yang H; Beutler B; Zhang D
Protein Cell; 2022 Aug; 13(8):559-579. PubMed ID: 34196950
[TBL] [Abstract][Full Text] [Related]
4. Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.
Urbanski LM; Leclair N; Anczuków O
Wiley Interdiscip Rev RNA; 2018 Jul; 9(4):e1476. PubMed ID: 29693319
[TBL] [Abstract][Full Text] [Related]
5. The nuts and bolts of the endogenous spliceosome.
Sperling R
Wiley Interdiscip Rev RNA; 2017 Jan; 8(1):. PubMed ID: 27465259
[TBL] [Abstract][Full Text] [Related]
6. [Targeting the spliceosome: A new therapeutic strategy to counteract chemotherapy resistance in lung cancer?].
Shreim A; Gazzeri S; Eymin B
Rev Mal Respir; 2024 Apr; 41(4):294-298. PubMed ID: 38461087
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer.
Jiménez-Vacas JM; Herrero-Aguayo V; Montero-Hidalgo AJ; Gómez-Gómez E; Fuentes-Fayos AC; León-González AJ; Sáez-Martínez P; Alors-Pérez E; Pedraza-Arévalo S; González-Serrano T; Reyes O; Martínez-López A; Sánchez-Sánchez R; Ventura S; Yubero-Serrano EM; Requena-Tapia MJ; Castaño JP; Gahete MD; Luque RM
EBioMedicine; 2020 Jan; 51():102547. PubMed ID: 31902674
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Targeting of RNA Splicing in Cancer.
Bonner EA; Lee SC
Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510283
[TBL] [Abstract][Full Text] [Related]
9. The spliceosome: a self-organized macromolecular machine in the nucleus?
Rino J; Carmo-Fonseca M
Trends Cell Biol; 2009 Aug; 19(8):375-84. PubMed ID: 19616950
[TBL] [Abstract][Full Text] [Related]
10. A genome-wide siRNA screen for regulators of tumor suppressor p53 activity in human non-small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment.
Siebring-van Olst E; Blijlevens M; de Menezes RX; van der Meulen-Muileman IH; Smit EF; van Beusechem VW
Mol Oncol; 2017 May; 11(5):534-551. PubMed ID: 28296343
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of splicing variants and spliceosome components in breast cancer.
Gahete MD; Herman-Sanchez N; Fuentes-Fayos AC; Lopez-Canovas JL; Luque RM
Endocr Relat Cancer; 2022 Sep; 29(9):R123-R142. PubMed ID: 35728261
[TBL] [Abstract][Full Text] [Related]
12. Regulation of alternative mRNA splicing: old players and new perspectives.
Dvinge H
FEBS Lett; 2018 Sep; 592(17):2987-3006. PubMed ID: 29856907
[TBL] [Abstract][Full Text] [Related]
13. Nuclear organization of pre-mRNA splicing factors.
Sleeman JE; Lamond AI
Curr Opin Cell Biol; 1999 Jun; 11(3):372-7. PubMed ID: 10395556
[TBL] [Abstract][Full Text] [Related]
14. Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer.
Zhang D; Hu Q; Liu X; Ji Y; Chao HP; Liu Y; Tracz A; Kirk J; Buonamici S; Zhu P; Wang J; Liu S; Tang DG
Nat Commun; 2020 Apr; 11(1):2089. PubMed ID: 32350277
[TBL] [Abstract][Full Text] [Related]
15. The role of alternative splicing in cancer: From oncogenesis to drug resistance.
Sciarrillo R; Wojtuszkiewicz A; Assaraf YG; Jansen G; Kaspers GJL; Giovannetti E; Cloos J
Drug Resist Updat; 2020 Dec; 53():100728. PubMed ID: 33070093
[TBL] [Abstract][Full Text] [Related]
16. DLP, a novel Dim1 family protein implicated in pre-mRNA splicing and cell cycle progression.
Sun X; Zhang H; Wang D; Ma D; Shen Y; Shang Y
J Biol Chem; 2004 Jul; 279(31):32839-47. PubMed ID: 15161931
[TBL] [Abstract][Full Text] [Related]
17. Native spliceosomes assemble with pre-mRNA to form supraspliceosomes.
Azubel M; Habib N; Sperling R; Sperling J
J Mol Biol; 2006 Mar; 356(4):955-66. PubMed ID: 16386271
[TBL] [Abstract][Full Text] [Related]
18. Viral interactions with components of the splicing machinery.
Meyer F
Prog Mol Biol Transl Sci; 2016; 142():241-68. PubMed ID: 27571697
[TBL] [Abstract][Full Text] [Related]
19. Targeting splicing factors for cancer therapy.
Bashari A; Siegfried Z; Karni R
RNA; 2023 Apr; 29(4):506-515. PubMed ID: 36697261
[TBL] [Abstract][Full Text] [Related]
20. The Supraspliceosome - A Multi-Task Machine for Regulated Pre-mRNA Processing in the Cell Nucleus.
Shefer K; Sperling J; Sperling R
Comput Struct Biotechnol J; 2014 Sep; 11(19):113-22. PubMed ID: 25408845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
